Thrombotic microangiopathy - Revision history

Aidan at 00:07, 21 June 2025

2025-06-21T00:07:32Z

@@ Line 41: / Line 41: @@
+|
 |}
 [[Category:Hematology]]
 [[Category:Thrombosis]]

Aidan at 11:26, 19 March 2024

2024-03-19T11:26:06Z

← Older revision		Revision as of 11:26, 19 March 2024
Line 10:		Line 10:
	\|-		\|-
	\|[[Hemolytic-uremic syndrome]]		\|[[Hemolytic-uremic syndrome]]
	\|PT/INR and PTT are normal		\|PT/INR and PTT are normal, severe AKI
	\|-		\|-
	\|[[Atypical hemolytic-uremic syndrome]]		\|[[Atypical hemolytic-uremic syndrome]]
	\|PT/INR and PTT are normal		\|PT/INR and PTT are normal, severe AKI
	\|-		\|-
	\|[[HELLP syndrome]]		\|[[HELLP syndrome]]
			\|pregnancy
	\|
	\|-		\|-
	! colspan="2" \|Secondary		! colspan="2" \|Secondary

Aidan at 11:25, 19 March 2024

2024-03-19T11:25:04Z

@@ Line 1: / Line 1: @@
 *Syndrome of [[microangiopathic hemolytic anemia]], [[thrombocytopenia]], and microvascular thrombosis leading to organ dysfunction
 [[Category:Hematology]]
 [[Category:Thrombosis]]

Aidan at 13:51, 20 April 2023

2023-04-20T13:51:29Z

← Older revision		Revision as of 13:51, 20 April 2023
Line 7:		Line 7:
	*Associated with coexisting condition		*Associated with coexisting condition
	**Autoimmune disease, including [[systemic lupus erythematosus]] or [[antiphospholid antibody syndrome]]		**Autoimmune disease, including [[systemic lupus erythematosus]] or [[antiphospholid antibody syndrome]]
	**~~Drugs~~, including [[quinine]], [[ticlopidine]], and [[chemotherapy]] ([[mitomycin]], [[gemcitabine]], [[cyclosporine]], and [[tacrolimus]], though it may also be caused by the underlying condition)		**[[Drug-induced thrombotic microangiopathy]], including [[quinine]], [[ticlopidine]], and [[chemotherapy]] ([[mitomycin]], [[gemcitabine]], [[cyclosporine]], and [[tacrolimus]], though it may also be caused by the underlying condition)
			**[[Sepsis]] and [[secondary hemolytic-uremic syndrome]] (usually from [[Streptococcus pneumoniae]] or [[influenza]])
	**[[Sepsis]]
	**[[DIC]]		**[[DIC]]
	**[[Malignancy]]		**[[Malignancy]]

Aidan at 11:45, 15 August 2020

2020-08-15T11:45:30Z

← Older revision		Revision as of 11:45, 15 August 2020
Line 1:		Line 1:
			*Syndrome of [[microangiopathic hemolytic anemia]], [[thrombocytopenia]], and microvascular thrombosis leading to organ dysfunction
⚫	* [[Thrombotic thrombocytopenia purpura]]
			*Primary
⚫	* [[Hemolytic-uremic syndrome]]
		⚫	**[[Thrombotic thrombocytopenia purpura]]
⚫	* [[Atypical hemolytic-uremic syndrome]]
		⚫	**[[Hemolytic-uremic syndrome]]
		⚫	**[[Atypical hemolytic-uremic syndrome]]
			**[[HELLP syndrome]]
			*Associated with coexisting condition
			**Autoimmune disease, including [[systemic lupus erythematosus]] or [[antiphospholid antibody syndrome]]
			**Drugs, including [[quinine]], [[ticlopidine]], and [[chemotherapy]] ([[mitomycin]], [[gemcitabine]], [[cyclosporine]], and [[tacrolimus]], though it may also be caused by the underlying condition)
			**[[Sepsis]]
			**[[DIC]]
			**[[Malignancy]]
			**[[HIV]]

	[[Category:Hematology]]		[[Category:Hematology]]

Aidan: Created page with "* Thrombotic thrombocytopenia purpura * Hemolytic-uremic syndrome * Atypical hemolytic-uremic syndrome Category:Hematology Category:Thrombosis"

2020-08-15T11:32:33Z

Created page with "* Thrombotic thrombocytopenia purpura * Hemolytic-uremic syndrome * Atypical hemolytic-uremic syndrome Category:Hematology Category:Thrombosis"

New page

* [[Thrombotic thrombocytopenia purpura]]
* [[Hemolytic-uremic syndrome]]
* [[Atypical hemolytic-uremic syndrome]]

[[Category:Hematology]]
[[Category:Thrombosis]]